Phreesia, Inc. (NYSE:PHR) Shares Sold by Lazard Asset Management LLC

Lazard Asset Management LLC lowered its holdings in Phreesia, Inc. (NYSE:PHR) by 35.1% in the 4th quarter, Holdings Channel.com reports. The fund owned 42,977 shares of the company’s stock after selling 23,267 shares during the quarter. Lazard Asset Management LLC’s holdings in Phreesia were worth $1,081,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Deerfield Management Company L.P. Series C grew its holdings in Phreesia by 133.6% during the 4th quarter. Deerfield Management Company L.P. Series C now owns 1,271,832 shares of the company’s stock valued at $31,999,000 after purchasing an additional 727,384 shares in the last quarter. Greenhouse Funds LLLP grew its holdings in Phreesia by 27.9% during the 4th quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company’s stock valued at $72,307,000 after purchasing an additional 626,579 shares in the last quarter. Park West Asset Management LLC acquired a new stake in Phreesia during the 4th quarter valued at $10,657,000. ExodusPoint Capital Management LP grew its holdings in Phreesia by 448.6% during the 4th quarter. ExodusPoint Capital Management LP now owns 174,971 shares of the company’s stock valued at $4,402,000 after purchasing an additional 143,077 shares in the last quarter. Finally, ArrowMark Colorado Holdings LLC grew its holdings in Phreesia by 41.2% during the 4th quarter. ArrowMark Colorado Holdings LLC now owns 484,617 shares of the company’s stock valued at $12,193,000 after purchasing an additional 141,411 shares in the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

Phreesia Price Performance

Shares of PHR stock opened at $25.36 on Tuesday. The firm has a fifty day moving average of $25.32 and a two-hundred day moving average of $25.08. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $30.53. The firm has a market cap of $1.51 billion, a P/E ratio of -17.25 and a beta of 0.74.

Insider Transactions at Phreesia

In other news, SVP David Linetsky sold 4,499 shares of the firm’s stock in a transaction dated Wednesday, April 16th. The shares were sold at an average price of $23.73, for a total value of $106,761.27. Following the transaction, the senior vice president now directly owns 217,239 shares in the company, valued at approximately $5,155,081.47. This trade represents a 2.03% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Yvonne Hui sold 1,878 shares of the firm’s stock in a transaction dated Tuesday, April 8th. The stock was sold at an average price of $23.85, for a total transaction of $44,790.30. Following the completion of the transaction, the insider now owns 28,449 shares in the company, valued at approximately $678,508.65. The trade was a 6.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 42,474 shares of company stock worth $1,023,208. 5.80% of the stock is currently owned by insiders.

Analyst Ratings Changes

PHR has been the subject of a number of recent analyst reports. Needham & Company LLC reaffirmed a “buy” rating and set a $29.00 price target on shares of Phreesia in a report on Thursday, March 13th. Canaccord Genuity Group raised their price target on shares of Phreesia from $34.00 to $35.00 and gave the company a “buy” rating in a report on Thursday, March 13th. KeyCorp lowered their price target on shares of Phreesia from $30.00 to $28.00 and set an “overweight” rating for the company in a report on Wednesday, April 16th. Piper Sandler reissued an “overweight” rating and set a $33.00 price objective (up from $31.00) on shares of Phreesia in a report on Wednesday, January 29th. Finally, DA Davidson decreased their price objective on shares of Phreesia from $36.00 to $34.00 and set a “buy” rating for the company in a report on Monday, April 14th. Twelve investment analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $31.33.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.